Cargando…

The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study

BACKGROUND: Papillary thyroid carcinoma PTC is the most prevalent of all thyroid carcinomas. On the other hand, Hashimoto’s thyroiditis (HT), as part of the spectrum of autoimmune thyroid diseases, is a major cause of thyroid hypofunction worldwide. Several studies have aimed to indicate a possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasiri, Shirzad, Yazd, Seyed Mostafa Meshkati, Gholami, Mahsa, Shahriarirad, Sepehr, Sharghi, Sina, Shahriarirad, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037788/
https://www.ncbi.nlm.nih.gov/pubmed/36964545
http://dx.doi.org/10.1186/s12902-023-01322-5
_version_ 1784911950152466432
author Nasiri, Shirzad
Yazd, Seyed Mostafa Meshkati
Gholami, Mahsa
Shahriarirad, Sepehr
Sharghi, Sina
Shahriarirad, Reza
author_facet Nasiri, Shirzad
Yazd, Seyed Mostafa Meshkati
Gholami, Mahsa
Shahriarirad, Sepehr
Sharghi, Sina
Shahriarirad, Reza
author_sort Nasiri, Shirzad
collection PubMed
description BACKGROUND: Papillary thyroid carcinoma PTC is the most prevalent of all thyroid carcinomas. On the other hand, Hashimoto’s thyroiditis (HT), as part of the spectrum of autoimmune thyroid diseases, is a major cause of thyroid hypofunction worldwide. Several studies have aimed to indicate a possible correlation between PTC and HT over the years. This study aims to investigate the correlation between HT disease and PTC tumor invasion rate. METHOD: In the present cross-sectional study, PTC patients with HT were selected among patients referred to the surgical ward of Shariati hospital from 2016 to 2019 and compared in terms of tumor invasion and central LN dissection. Also, a similar group of PTC patients without HT undergoing total thyroidectomy was selected for comparison. The tumor invasion rate was assessed based on invasion indices obtained from postoperative permanent pathology specimens. These indices included tumor type and size, number of involved LNs, lymphovascular involvement, perineural involvement, thyroid capsule involvement, multifocal or unifocal tumor, extrathyroidal proliferation, marginal status, and necrosis. Data were obtained and compared in the two groups with SPSS version 22.0 software. RESULTS: Based on the postoperative pathology reports, 50 (56.2%) PTC patients with Hashimoto thyroiditis were compared against 39 PTC patients without Hashimoto thyroiditis. No significant difference was found between the two groups regarding tumor invasion factors such as multifocality, lymphovascular invasion, marginal invasion, extrathyroidal invasion, capsular invasion, and necrosis. CONCLUSION: HT could not be mentioned as an aggravating factor of PTC invasion based on the invasion factors evaluated in pathology specimens.
format Online
Article
Text
id pubmed-10037788
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100377882023-03-25 The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study Nasiri, Shirzad Yazd, Seyed Mostafa Meshkati Gholami, Mahsa Shahriarirad, Sepehr Sharghi, Sina Shahriarirad, Reza BMC Endocr Disord Research BACKGROUND: Papillary thyroid carcinoma PTC is the most prevalent of all thyroid carcinomas. On the other hand, Hashimoto’s thyroiditis (HT), as part of the spectrum of autoimmune thyroid diseases, is a major cause of thyroid hypofunction worldwide. Several studies have aimed to indicate a possible correlation between PTC and HT over the years. This study aims to investigate the correlation between HT disease and PTC tumor invasion rate. METHOD: In the present cross-sectional study, PTC patients with HT were selected among patients referred to the surgical ward of Shariati hospital from 2016 to 2019 and compared in terms of tumor invasion and central LN dissection. Also, a similar group of PTC patients without HT undergoing total thyroidectomy was selected for comparison. The tumor invasion rate was assessed based on invasion indices obtained from postoperative permanent pathology specimens. These indices included tumor type and size, number of involved LNs, lymphovascular involvement, perineural involvement, thyroid capsule involvement, multifocal or unifocal tumor, extrathyroidal proliferation, marginal status, and necrosis. Data were obtained and compared in the two groups with SPSS version 22.0 software. RESULTS: Based on the postoperative pathology reports, 50 (56.2%) PTC patients with Hashimoto thyroiditis were compared against 39 PTC patients without Hashimoto thyroiditis. No significant difference was found between the two groups regarding tumor invasion factors such as multifocality, lymphovascular invasion, marginal invasion, extrathyroidal invasion, capsular invasion, and necrosis. CONCLUSION: HT could not be mentioned as an aggravating factor of PTC invasion based on the invasion factors evaluated in pathology specimens. BioMed Central 2023-03-24 /pmc/articles/PMC10037788/ /pubmed/36964545 http://dx.doi.org/10.1186/s12902-023-01322-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Nasiri, Shirzad
Yazd, Seyed Mostafa Meshkati
Gholami, Mahsa
Shahriarirad, Sepehr
Sharghi, Sina
Shahriarirad, Reza
The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study
title The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study
title_full The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study
title_fullStr The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study
title_full_unstemmed The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study
title_short The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study
title_sort evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037788/
https://www.ncbi.nlm.nih.gov/pubmed/36964545
http://dx.doi.org/10.1186/s12902-023-01322-5
work_keys_str_mv AT nasirishirzad theevaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy
AT yazdseyedmostafameshkati theevaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy
AT gholamimahsa theevaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy
AT shahriariradsepehr theevaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy
AT sharghisina theevaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy
AT shahriariradreza theevaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy
AT nasirishirzad evaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy
AT yazdseyedmostafameshkati evaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy
AT gholamimahsa evaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy
AT shahriariradsepehr evaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy
AT sharghisina evaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy
AT shahriariradreza evaluationoflocoregionaltumoralinvolvementinthecooccurrenceofhashimotothyroiditiswithpapillarythyroidcanceracasecontrolledstudy